Home > Cashflow Statement > DIVIS LABORATORIES

DIVIS LABORATORIES
Cash Flow from Financing Activities

    Back to Cashflow Statement
DIVIS LABORATORIES is part of below Screeners ↓
Top Large Cap Stocks with Best Fundamentals
Best Quarterly Growth Large Cap Stocks
AD     Remove this Ad

DIVIS LABORATORIES Last 5 Year Cash Flow from Financing Activities History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
Cash Flow from Financing Activities ₹-799 Cr₹-799 Cr₹-797 Cr₹-532 Cr₹-35 Cr

What is the latest Cash Flow from Financing Activities ratio of DIVIS LABORATORIES ?

The latest Cash Flow from Financing Activities ratio of DIVIS LABORATORIES is ₹-799 Cr based on Mar2025 Consolidated results.
Year Cash Flow from Financing Activities
Mar2025₹-799 Cr
Mar2024₹-799 Cr
Mar2023₹-797 Cr
Mar2022₹-532 Cr
Mar2021₹-35 Cr

How is Cash Flow from Financing Activities of DIVIS LABORATORIES Trending?

Years Cash Flow from Financing Activities % Change
Mar2025 ₹-799 Cr
Negative
Mar2024 ₹-799 Cr
Negative
Mar2023 ₹-797 Cr
Negative
Mar2022 ₹-532 Cr
Negative
Mar2021 ₹-35 Cr -

Compare Cash Flow from Financing Activities of peers of DIVIS LABORATORIES

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
DIVIS LABORATORIES ₹162,390.4 Cr -1.5% -7.3% 2.3% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹408,991.0 Cr 0.1% -3.2% -2.6% Stock Analytics
TORRENT PHARMACEUTICALS ₹135,229.0 Cr -1.3% -0.7% 24.4% Stock Analytics
CIPLA ₹108,441.0 Cr 1.5% -8.1% -6.3% Stock Analytics
DR REDDYS LABORATORIES ₹106,407.0 Cr 3.2% 5.6% 3.1% Stock Analytics
MANKIND PHARMA ₹85,977.0 Cr -3.4% -7.7% -20.3% Stock Analytics


DIVIS LABORATORIES Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
DIVIS LABORATORIES

-1.5%

-7.3%

2.3%

SENSEX

2.9%

-1.1%

8.5%


You may also like the below Video Courses